The therapeutic potential for targetting potassium channels: are dendrotoxins a suitable basis for drug design?
Alan L. Harvey, Mark J. Dufton*
*Corresponding author for this work
Research output: Contribution to journal › Review article › peer-review
2
Link opens in a new tab
Citations
(Scopus)